Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Neuropsychobiology ; 80(1): 64-73, 2021.
Article in English | MEDLINE | ID: mdl-32659769

ABSTRACT

BACKGROUND/AIMS: Opioid dependence is a severe disease which is associated with a high risk of relapse, even in cases of successful withdrawal therapy. Studies have shown alterations of the hypothalamic-pituitary-gonadal axis in opioid-dependent patients, such as decreased testosterone serum levels in affected males. Sex hormones and the steroid 5-alpha-reductase 2 (SRD5A2) V89L polymorphism are associated with craving during alcohol withdrawal, but little is known about their impact on symptomatology of opioid dependence. METHODS: In this study, we analyzed 2 independent male cohorts of opioid-dependent patients for possible alterations in testosterone serum levels compared to non-opioid-dependent controls. In one of the cohorts, we additionally investigated associations of testosterone serum levels and 3 SRD5A2 polymorphisms with symptoms of opioid dependence, measured by the Heroin Craving Questionnaire (HCQ). RESULTS: In the patient groups, we found significantly decreased testosterone serum levels compared to the control groups. Furthermore, we found significant associations of both the testosterone serum levels and the SRD5A2 V89L polymorphism with opioid craving assessed by the HCQ. CONCLUSION: Our data show a possible role of testosterone metabolism in opioid dependence, which may be relevant for the establishment of future treatment strategies.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Craving/physiology , Membrane Proteins/genetics , Opioid-Related Disorders/blood , Opioid-Related Disorders/genetics , Opioid-Related Disorders/physiopathology , Testosterone/blood , Adult , Cohort Studies , Humans , Male , Polymorphism, Genetic
2.
PLoS One ; 7(11): e50069, 2012.
Article in English | MEDLINE | ID: mdl-23166823

ABSTRACT

BACKGROUND: There is an inverse secular trend between the incidence of obesity and gastric colonization with Helicobacter pylori, a bacterium that can affect the secretion of gastric hormones that relate to energy homeostasis. H. pylori strains that carry the cag pathogenicity island (PAI) interact more intimately with gastric epithelial cells and trigger more extensive host responses than cag(-) strains. We hypothesized that gastric colonization with H. pylori strains differing in cag PAI status exert distinct effects on metabolic and inflammatory phenotypes. METHODOLOGY/PRINCIPAL FINDINGS: To test this hypothesis, we examined metabolic and inflammatory markers in db/db mice and mice with diet-induced obesity experimentally infected with isogenic forms of H. pylori strain 26695: the cag PAI wild-type and its cag PAI mutant strain 99-305. H. pylori colonization decreased fasting blood glucose levels, increased levels of leptin, improved glucose tolerance, and suppressed weight gain. A response found in both wild-type and mutant H. pylori strain-infected mice included decreased white adipose tissue macrophages (ATM) and increased adipose tissue regulatory T cells (Treg) cells. Gene expression analyses demonstrated upregulation of gastric PPAR γ-responsive genes (i.e., CD36 and FABP4) in H. pylori-infected mice. The loss of PPAR γ in immune and epithelial cells in mice impaired the ability of H. pylori to favorably modulate glucose homeostasis and ATM infiltration during high fat feeding. CONCLUSIONS/SIGNIFICANCE: Gastric infection with some commensal strains of H. pylori ameliorates glucose homeostasis in mice through a PPAR γ-dependent mechanism and modulates macrophage and Treg cell infiltration into the abdominal white adipose tissue.


Subject(s)
Gastric Mucosa/microbiology , Genomic Islands/genetics , Helicobacter Infections/metabolism , Helicobacter pylori/growth & development , Homeostasis/physiology , Obesity/microbiology , PPAR gamma/metabolism , Adipose Tissue/cytology , Adipose Tissue/immunology , Animals , Blood Glucose , Body Weight , CD36 Antigens/metabolism , Enzyme-Linked Immunosorbent Assay , Fatty Acid-Binding Proteins/metabolism , Flow Cytometry , Gastric Mucosa/immunology , Gastric Mucosa/metabolism , Gene Expression Profiling , Ghrelin/blood , Helicobacter Infections/immunology , Helicobacter pylori/genetics , Insulin/blood , Leptin/blood , Macrophages/immunology , Mice , T-Lymphocytes, Regulatory/immunology
SELECTION OF CITATIONS
SEARCH DETAIL